Urokinase plasminogen activator, a strong independent prognostic factor in breast cancer, analysed in steroid receptor cytosols with a luminometric immunoassay. [electronic resource]
Producer: 19970401Description: 793-801 p. digitalISSN:- 0959-8049
- Antineoplastic Agents, Hormonal -- therapeutic use
- Biomarkers, Tumor -- analysis
- Breast Neoplasms -- drug therapy
- Chemotherapy, Adjuvant
- Cytosol -- enzymology
- Disease-Free Survival
- Female
- Humans
- Immunoassay -- methods
- Lymphatic Metastasis
- Middle Aged
- Multivariate Analysis
- Prognosis
- Prospective Studies
- Tamoxifen -- therapeutic use
- Urokinase-Type Plasminogen Activator -- analysis
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.